RARE FOCUS

RARE COMMITMENT

RARE PASSION

Focus on Bridging Treatment Gaps

At Strongbridge Biopharma, our focus on rare diseases has resulted in a portfolio of innovative treatments for rare neuromuscular and endocrine conditions, including the commercialization of KEVEYIS and MACRILEN in the U.S.

Committed to Positive Results

At Strongbridge Biopharma, we are committed to delivering better results for patients, healthcare providers, employees, and investors.

Learn more about the Strongbridge difference

Passion for Compassion

The Strongbridge team is passionate about making a positive difference in the lives of patients with rare diseases. It’s why we’re here.

Meet the Strongbridge leadership team

© 2018 Strongbridge Biopharma plc
STRONGBRIDGE BIOPHARMA® is a registered trademark of the Strongbridge Biopharma plc. companies, which include Strongbridge Ireland Limited and Strongbridge U.S. Inc.
KEVEYIS® is a registered trademark licensed exclusively in the U.S. to Strongbridge Biopharma plc.
MACRILEN is a trademark of Aeterna Zentaris GmbH, licensed exclusively in the U.S. and Canada to Strongbridge Ireland Limited.
MLR-0010 V13 01/2018

900 Northbrook Drive, Suite 200
Trevose, PA 19053
United States
Phone: +1 610-254-9200
info@strongbridgebio.com

Privacy Statement
Compliance Program